Back to Search
Start Over
Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma.
- Source :
-
Cancer research [Cancer Res] 2009 Mar 15; Vol. 69 (6), pp. 2365-74. Date of Electronic Publication: 2009 Mar 03. - Publication Year :
- 2009
-
Abstract
- Aberrant signaling of the nuclear facotr (NF-kappaB) pathway has been identified as a mediator of survival and apoptosis resistance in leukemias and lymphomas. Here, we report that cell death of cutaneous T-cell lymphoma cell lines induced by inhibition of the NF-kappaB pathway is independent of caspases or classic death receptors. We found that free intracellular iron and reactive oxygen species (ROS) are the main mediators of this cell death. Antioxidants such as N-Acetyl-l-cysteine and glutathione or the iron chelator desferrioxamine effectively block cell death in cutaneous T-cell lymphoma cell lines or primary T cells from Sézary patients. We show that inhibition of constitutively active NF-kappaB causes down-regulation of ferritin heavy chain (FHC) that leads to an increase of free intracellular iron, which, in turn, induces massive generation of ROS. Furthermore, direct down-regulation of FHC by siRNA caused a ROS-dependent cell death. Finally, high concentrations of ROS induce cell death of malignant T cells. In contrast, T cells isolated from healthy donors do not display down-regulation of FHC and, therefore, do not show an increase in iron and cell death upon NF-kappaB inhibition. In addition, in a murine T-cell lymphoma model, we show that inhibition of NF-kappaB and subsequent down-regulation of FHC significantly delays tumor growth in vivo. Thus, our results promote FHC as a potential target for effective therapy in lymphomas with aberrant NF-kappaB signaling.
- Subjects :
- Animals
Apoferritins biosynthesis
Apoferritins genetics
Cell Death drug effects
Cell Death physiology
Cell Line, Tumor
Down-Regulation
Ferrous Compounds pharmacology
Humans
Lymphoma, T-Cell, Cutaneous drug therapy
Lymphoma, T-Cell, Cutaneous genetics
Lymphoma, T-Cell, Cutaneous pathology
Mice
Mice, Inbred C57BL
NF-kappa B metabolism
Oxidative Stress
Peptides pharmacology
RNA, Small Interfering genetics
Sezary Syndrome drug therapy
Sezary Syndrome immunology
Sezary Syndrome metabolism
Sezary Syndrome pathology
Signal Transduction drug effects
Skin Neoplasms genetics
Skin Neoplasms immunology
Skin Neoplasms pathology
T-Lymphocytes drug effects
T-Lymphocytes metabolism
T-Lymphocytes pathology
Iron metabolism
Lymphoma, T-Cell, Cutaneous metabolism
NF-kappa B antagonists & inhibitors
Reactive Oxygen Species metabolism
Skin Neoplasms metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1538-7445
- Volume :
- 69
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Cancer research
- Publication Type :
- Academic Journal
- Accession number :
- 19258503
- Full Text :
- https://doi.org/10.1158/0008-5472.CAN-08-3221